J Pharm Pharmacogn Res 3(suppl. 1): S154, 2015
Proceedings of the 4th International Symposium on Pharmacology of Natural Products FAPRONATURA 2015 September 21st-25th, 2015; Cuban Society of Pharmacology. Topes de Collantes, Sancti Spiritus, Cuba.
PCT-62: USE OF MEDICINAL PLANTS INDIVIDUALLY IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS
Méndez-Alonso CM, Cardoso-Suárez T.
Introduction: Acute respiratory infections (ARI) have been treated with medicinal plants, but its effects in practice have been poorly evaluated. In this study, the effects of individualized use of medicinal plants in patients with ARI, are described. Methods: A retrospective study involving 28 patients, aged 18 to 75 years old, with ARI between the second and third day of starting symptoms is made. Patterns according to Traditional Chinese Medicine (TCM) were identified according to symptoms: Wind cold, wind heat, wind dampness, wind cold dampness and wind heat dampness. Medicinal plants were prescribed individually as the patterns found and season of the year in which symptoms appear. Progression of symptoms like fever, general condition, cough, sputum, dyspnea and complications, was recorded daily. Results: The patterns prevailing were wind heat dampness (35.7%), wind cold dampness (25.0%) and cold wind (17.9%). Common plants used were: Bejuco ubí (Cissus sicyoides L.), salvia de Castilla (Salvia officinalis L.) and sour orange (Citrus aurantium L.). Slight improvement of symptoms was observed at day 2nd of treatment in 89.2% of patients. At the day 5th, intense improvement in 92.8% was noted. At the 7th day, total resolution in 96.4% of patients was observed. One patient achieved only slight improvement. Mild asthenia was reported in 60% of patients. Conclusions: The use of plants individually appears safe and may be effective in resolving symptoms in IRA. It is suggested to do controlled clinical study to assess the efficacy of this intervention.
Citation Format: Méndez-Alonso CM, Cardoso-Suárez T (2015) Use of medicinal plants individually in the treatment of acute respiratory infections. [Abstract]. In: Proceedings of the FAPRONATURA 2015; 2015 Sep 21-25; Topes de Collantes, Sancti Spiritus: CSF. J Pharm Pharmacogn Res 3(Suppl. 1): S154. Abstract nr PCT-62.